Aster DM Healthcare Q1 FY27 results (Apr–Jun 2026) and concall

Healthcare · Concall AI · Call held 5 Aug 2026

Company page: Aster DM Healthcare share price, financials & guidance record

Aster DM Healthcare Limited reported a strong Q1 FY27, with the combined proforma entity achieving 20% YoY revenue growth to INR 2,597 crores and 30% YoY EBITDA growth to INR 576 crores, expanding margins to 22.2%. The successful merger with Quality Care has created a unified healthcare platform with significant operational depth and synergy potential, driving growth through increased patient volumes, higher occupancy, and strategic expansion into super-specialty care and Tier 2/3 markets. The company is focused on leveraging scale and clinical excellence to achieve long-term value creation an

You’re reading a preview. Opening the full call uses 1 concall credit.

What they filed

Q1 FY27: revenue up 21.6%, net profit down 69.1% against the same quarter last year.

₹ Cr · quarterly

Line item	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Revenue	1,086	1,050	1,000	1,078	1,197 +10%	1,186 +13%	1,182 +18%	1,311 +22%
Expenses	869	864	818	876	961	983	958	1,055
EBITDA	217	186	182	202	236 +9%	202 +9%	224 +23%	256 +27%
Margin	20%	18%	18%	19%	20%	17%	19%	20%
Other income	35	9	5	29	28	0	37	-77
Interest	31	31	32	31	31	31	30	31
Depreciation	62	62	64	63	66	68	67	69
Profit before tax	159	102	91	136	167 +5%	103 +1%	163 +79%	78 −43%
Tax rate	33%	37%	6%	31%	27%	43%	6%	62%
Net profit	106	64	86	94	121 +14%	59 −8%	154 +79%	29 −69%
EPS	1.94	1.14	1.58	1.65	2.12	1.01	2.71	0.31

How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.

What they filed

More Healthcare earnings calls